Country: Ġappun
Lingwa: Ingliż
Sors: すりの適正使用協議会 RAD-AR Council, Japan
Etilefrine hydrochloride
Sanofi K.K.
Etilefrine hydrochloride
injection
Drug Information Sheet("Kusuri-no-Shiori") Injection Published: 09/2019 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: EFFORTIL INJECTION 10MG ACTIVE INGREDIENT: Etilefrine hydrochloride DOSAGE FORM: injection IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine increases blood pressure by increasing the volume of blood pumped out into the systemic circulation through increase in myocardial contractility. It is usually used as adjunctive treatment for acute hypotension or shock associated with orthostatic hypotension or various types of diseases/clinical conditions. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have hyperthyroidism, hypertension or ventricular tachycardia. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE) ・ Your dosing schedule prescribed by your doctor is(( to be written by a healthcare professional )) ・In general, for adults, inject this medicine subcutaneously, intramuscularly or intravenously, only when symptoms are present. PRECAUTIONS WHILE TAKING THIS MEDICINE POSSIBLE ADVERSE REACTIONS TO THIS MEDICINE The most commonly reported adverse reactions include headache, palpitation and rash. If any of these symptoms occur, consult with your Aqra d-dokument sħiħ